Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2014, Article ID 154357, 8 pages
http://dx.doi.org/10.1155/2014/154357
Research Article

Design, Synthesis, and Molecular Docking of 1-(1-(4-Chlorophenyl)-2-(phenylsulfonyl)ethylidene)-2-phenylhydrazine as Potent Nonazole Anticandidal Agent

1Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
2Department of Clinical Microbiology and Immunology, College of Medicine, Mansoura University, Mansoura 35516, Egypt
3Department of Pharmaceutical Chemistry, College of Pharmacy, Egyptian Russian University, P.O. Box 11829, Badr City, Cairo, Egypt
4Stem Cell and Tissue Re-Engineering Program, Research Center, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, MBC 03, Riyadh 11211, Saudi Arabia
5Department of Applied Organic Chemistry, National Research Center, Dokki, Cairo 12622, Egypt

Received 18 October 2014; Revised 14 December 2014; Accepted 14 December 2014; Published 31 December 2014

Academic Editor: Tanaji Talele

Copyright © 2014 Hazem A. Ghabbour et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Segura, A. M. Puga, G. Burillo et al., “Materials with fungi-bioinspired surface for efficient binding and fungi-sensitive release of antifungal agents,” Biomacromolecules, vol. 15, no. 5, pp. 1860–1870, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Ghannoum and J. R. Perfect, “History of antifungals,” in Antifungal Therapy, chapter 1, pp. 1–10, Informa Healthcare, 2010. View at Google Scholar
  3. S. Schelenz, “Management of candidiasis in the intensive care unit,” The Journal of Antimicrobial Chemotherapy, vol. 61, supplement 1, pp. i31–i34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Chimenti, B. Bizzarri, A. Bolasco et al., “Synthesis and biological evaluation of novel 2,4-disubstituted-1,3-thiazoles as anti-Candida spp. agents,” European Journal of Medicinal Chemistry, vol. 46, no. 1, pp. 378–382, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Sheehan, C. A. Hitchcock, and C. M. Sibley, “Current and emerging azole antifungal agents,” Clinical Microbiology Reviews, vol. 12, no. 1, pp. 40–79, 1999. View at Google Scholar · View at Scopus
  6. D. Kong, M.-J. Lee, S. Lin, and E.-S. Kim, “Biosynthesis and pathway engineering of antifungal polyene macrolides in actinomycetes,” Journal of Industrial Microbiology and Biotechnology, vol. 40, no. 6, pp. 529–543, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Nowosielski, M. Hoffmann, L. S. Wyrwicz et al., “Detailed mechanism of squalene epoxidase inhibition by terbinafine,” Journal of Chemical Information and Modeling, vol. 51, no. 2, pp. 455–462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. B. Kurtz and J. H. Rex, “Glucan synthase inhibitors as antifungal agents,” Advances in Protein Chemistry, vol. 56, pp. 423–475, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. V. T. Andriole, “Current and future antifungal therapy: new targets for antifungal therapy,” International Journal of Antimicrobial Agents, vol. 16, no. 3, pp. 317–321, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. W. M. Holden, J. S. Fites, L. K. Reinert, and L. A. Rollins-Smith, “Nikkomycin Z is an effective inhibitor of the chytrid fungus linked to global amphibian declines,” Fungal Biology, vol. 118, no. 1, pp. 48–60, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Zervos and F. Meunier, “Fluconazole (Diflucan): a review,” International Journal of Antimicrobial Agents, vol. 3, no. 3, pp. 147–170, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. C. A. Hitchcock, K. Dickinson, S. B. Brown, E. G. V. Evans, and D. J. Adams, “Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14α-sterol demethylase purified from Candida albicans,” Biochemical Journal, vol. 266, no. 2, pp. 475–480, 1990. View at Google Scholar · View at Scopus
  13. Z. A. Kanafani and J. R. Perfect, “Resistance to antifungal agents: mechanisms and clinical impact,” Clinical Infectious Diseases, vol. 46, no. 1, pp. 120–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. B. A. Stuck, A. Blum, A. E. Hagner, T. Hummel, L. Klimek, and K. Hörmann, “Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis,” Allergy, vol. 58, no. 11, p. 1195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Legras, A.-M. Bergemer-Fouquet, and A.-P. Jonville-Bera, “Fatal hepatitis with leflunomide and itraconazole,” The American Journal of Medicine, vol. 113, no. 4, pp. 352–353, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Somchit, A. R. Norshahida, A. H. Hasiah, A. Zuraini, M. R. Sulaiman, and M. M. Noordin, “Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in vivo study,” Human and Experimental Toxicology, vol. 23, no. 11, pp. 519–525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. T. Slama, J. L. Hancock, T. Rho, L. Sambucetti, and K. A. Bachmann, “Influence of some novel N-substituted azoles and pyridines on rat hepatic CYP3A activity,” Biochemical Pharmacology, vol. 55, no. 11, pp. 1881–1892, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Wulff, M. J. Miller, W. Hänsel, S. Grissmer, M. D. Cahalan, and K. G. Chandy, “Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 14, pp. 8151–8156, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Plempel, “Experiences, recognitions and questions in azole antimycotics,” Japanese Journal of Medical Mycology, vol. 23, no. 1, pp. 17–27, 1982. View at Publisher · View at Google Scholar · View at Scopus
  20. R. A. Fromtling, “Overview of medically important antifungal azole derivatives,” Clinical Microbiology Reviews, vol. 1, no. 2, pp. 187–217, 1988. View at Google Scholar · View at Scopus
  21. R. L. Dyer, G. J. Ellames, B. J. Hamill, P. W. Manley, and A. M. S. Pope, “Synthesis of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agent,” Journal of Medicinal Chemistry, vol. 26, no. 3, pp. 442–445, 1983. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. H. Molina, J. Losá, A. M. Brocal, and A. Ventosa, “In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp,” Mycopathologia, vol. 118, no. 1, pp. 15–21, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Ayati, M. Falahati, H. Irannejad, and S. Emami, “Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones,” DARU Journal of Pharmaceutical Sciences, vol. 20, no. 1, article 46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. Altntop, A. Özdemir, G. Turan-Zitouni et al., “Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents,” European Journal of Medicinal Chemistry, vol. 58, pp. 299–307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. Neumann, A. Cammarata, G. Backes, G. E. Palmer, and B. S. Jursic, “Synthesis and antifungal activity of substituted 2,4,6-pyrimidinetrione carbaldehyde hydrazones,” Bioorganic & Medicinal Chemistry, vol. 22, no. 2, pp. 813–826, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Curti, M. Laget, A. O. Carle, A. Gellis, and P. Vanelle, “Rapid synthesis of sulfone derivatives as potential anti-infectious agents,” European Journal of Medicinal Chemistry, vol. 42, no. 6, pp. 880–884, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Xu, J. He, M. He et al., “Synthesis and antifungal activity of novel sulfone derivatives containing 1,3,4-oxadiazole moieties,” Molecules, vol. 16, no. 11, pp. 9129–9141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Muralikrishna, B. C. Venkatesh, V. Padmavathi, A. Padmaja, P. Kondaiah, and N. S. Krishna, “Synthesis, antimicrobial and cytotoxic activities of sulfone linked bis heterocycles,” European Journal of Medicinal Chemistry, vol. 54, pp. 605–614, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. A. Abdel-Aziz, H. A. Ghabbour, M. A. Bhat, and H.-K. Fun, “Microwave-assisted synthesis and characterization of certain oximes, hydrazones and olefins derived from β-keto sulfones,” Journal of Chemistry, vol. 2014, Article ID 532467, 6 pages, 2014. View at Publisher · View at Google Scholar
  30. A. M. Alafeefy, H. A. Abdel-Aziz, D. Vullo et al., “Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4] triazolo [3,4-b][1,3,4] thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties,” Bioorganic & Medicinal Chemistry, vol. 22, pp. 141–147, 2014. View at Google Scholar
  31. H. A. Abdel-Aziz, T. Elsaman, A. Al-Dhfyan, M. I. Attia, K. A. Al-Rashood, and A.-R. M. Al-Obaid, “Synthesis and anticancer potential of certain novel 2-oxo-N′-(2-oxoindolin-3-ylidene)-2 H-chromene-3-carbohydrazides,” European Journal of Medicinal Chemistry, vol. 70, pp. 358–363, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. H. A. Abdel-Aziz, P. Ahmad, A. Kadi, K. A. Al-Rashood, H. A. Ghabbour, and H.-K. Fun, “Unexpected ring-opening of 3-aroylbenzo[b]furans at room temperature: a new route for the construction of phenol-substituted pyrazoles,” Tetrahedron Letters, vol. 54, no. 26, pp. 3424–3426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Alafeefy, S. Isik, N. A. Al-Jaber et al., “Carbonic anhydrase inhibitors. Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiaeβ-carbonic anhydrase,” Bioorganic and Medicinal Chemistry Letters, vol. 23, no. 12, pp. 3570–3575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H. A. Abdel-Aziz, T. Aboul-Fadl, A.-R. M. Al-Obaid, M. Ghazzali, A. Al-Dhfyan, and A. Contini, “Design, synthesis and pharmacophoric model building of novel substituted nicotinic acid hydrazones with potential antiproliferative activity,” Archives of Pharmacal Research, vol. 35, no. 9, pp. 1543–1552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. H. A. Abdel-Aziz, H. S. A. El-Zahabi, and K. M. Dawood, “Microwave-assisted synthesis and in-vitro anti-tumor activity of 1, 3, 4-triaryl-5-N-arylpyrazole-carboxamides,” European Journal of Medicinal Chemistry, vol. 45, pp. 2427–2432, 2010. View at Google Scholar
  36. H. A. Abdel-Aziz and A. A. I. Mekawey, “Stereoselective synthesis and antimicrobial activity of benzofuran-based (1E)-1-(piperidin-1-yl)-N2-arylamidrazones,” European Journal of Medicinal Chemistry, vol. 44, no. 12, pp. 4985–4997, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Xiang, M. Ipek, V. Suri et al., “β-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action,” Bioorganic & Medicinal Chemistry, vol. 15, no. 13, pp. 4396–4405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Perez, M. Pauli, and P. Bazerque, “An antibiotic assay by the agar well diffusion method,” Acta Biologiae et Medicinal Experimentalis, vol. 15, pp. 113–115, 1990. View at Google Scholar
  39. O. N. Irobi, M. Moo-Young, and W. A. Anderson, “Antimicrobial activity of Annatto (Bixa orellana) extract,” Pharmaceutical Biology, vol. 34, no. 2, pp. 87–90, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Urzua, M. Caroli, L. Vasquez, L. Mendoza, M. Wilkens, and E. Tojo, “Antimicrobial study of the resinous exudate and of diterpenoids isolated from Eupatorium salvia (Asteraceae),” Journal of Ethnopharmacology, vol. 62, no. 3, pp. 251–254, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. Molegro Virtual Docker (MVD 2013.6.0.0), Molegro bioinformatics solutions, 2013, (Danish), http://www.molegro.com.
  42. S. M. Kerwin, “ChemBioOffice ultra 2010 suite,” Journal of the American Chemical Society, vol. 132, no. 7, pp. 2466–2467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. Marvinsketch, “version 6.1.0, Chemaxon company cheminformatics technology products services,” 2013, http://www.chemaxon.com/.
  44. E. Banfi, G. Scialino, D. Zampieri et al., “Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach,” Journal of Antimicrobial Chemotherapy, vol. 58, no. 1, pp. 76–84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. A. O. Sarhan, A. Al-Dhfyan, M. A. Al-Mozaini, C. N. Adra, and T. Aboul-Fadl, “Cell cycle disruption and apoptotic activity of 3-aminothiazolo[3,2-a]benzimidazole-2-carbonitrile and its homologues,” European Journal of Medicinal Chemistry, vol. 45, no. 6, pp. 2689–2694, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. L. M. Podust, T. L. Poulos, and M. R. Waterman, “Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3068–3073, 2001. View at Publisher · View at Google Scholar · View at Scopus